AKT1 and prostate carcinoma: A769662 (100 μM) has been demonstrated previously to inhibit basal Akt Ser473 phosphorylation in prostate cancer cell lines, yet stimulated Akt Ser473 phosphorylation at a lower concentration (50 μM) [55].